|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 38/47 | |||
| A61K 39/395 | |||
| A61K 31/573 |
| (11) | Number of the document | 3186281 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15760604.7 |
| Date of filing the European patent application | 2015-08-28 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/047588 |
| Date | 2015-08-28 |
| (87) | Number | WO 2016/033555 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 201462043351 P | 2014-08-28 | US |
| (72) |
ROSENGREN, Sanna, US
SHEPARD, H., Michael, US
THOMPSON, Curtis, B., US
|
| (73) |
Halozyme, Inc.,
11388 Sorrento Valley Road, San Diego, CA 92121,
US
|
| (54) | COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR |
| COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR |